At 9:30 a.m. on July 21, the groundbreaking ceremony of the "Biotechnology Product R & D and Production Base" project of Liaoning Chengda Biological Co., Ltd. was grandly held in Shenyang Hunnan Biomedical Industrial Park.

The new base is located in Shenyang Hunnan Biomedical Industrial Park, covering an area of about 172 acres, with flat terrain and convenient transportation. At the beginning of the rain, the straight road of the gorgeous rainbow door arch guard extended to the site of the groundbreaking ceremony. The company's leadership team and employee representatives, full of joy and pride, walked into the scene to take their seats and listen to the speeches of the leading guests who came to the groundbreaking ceremony. In the sound of salute, the company's executives held gold shovels in their hands, cultivated soil and laid the foundation, opening a new milestone in the history of Chengda biological development!

The construction of the R & D and production base for biotechnology products will be mainly used for the industrialization of the company's innovative varieties. The recombinant 15-valent HPV vaccine jointly developed by our company is currently the highest-priced HPV vaccine approved for clinical trials in the world. After the product is put into production and put on the market, it is expected to achieve a breakthrough in the localization of high-priced HPV vaccine. It has outstanding innovation and broad commercialization prospects, and also represents a new peak of the innovation ability and industrialization comprehensive strength of Chengda Biological Company. The total investment of this project is 1.4 billion yuan and the total construction area is about 180000 square meters. It is planned to be constructed in two phases. The first phase of the project will build a production workshop, R & D center, quality center and supporting public facilities for the 15-valent HPV vaccine to meet the needs of clinical trials, vaccine registration and commercialization. The second phase of the project will build a series of standardized workshops for biological products. The construction of the new base will accelerate the industrialization process of the company's products under research, further expand the company's production and operation space, and lay the foundation for the company to expand its industrial scale.

We have planned this new blueprint. Here, we will rely on the company's existing production technology advantages, product quality advantages and management advantages, use a variety of combined research and development models to develop new products and new technologies, further implement technological achievements, enrich diversified product layout, and launch more innovative and high-quality vaccine products. In the future, with this project as a new starting point, the great biological people will work hard, work hard, and create greater glory! With solid performance, give the community and investors the most real returns!